Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Crotedumab [USAN]
RN: 1452387-69-7
UNII: 4JQ68PW6XF

Note

  • a glucagon receptor inhibitor in clinical trials (2015).

Molecular Formula

  • C6518-H10044-N1732-O2052-S46
 

Classification Code

  • Treatment of Diabetes
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)

Names and Synonyms

Name of Substance

  • Crotedumab [USAN]

Synonyms

  • Crotedumab
  • Immunoglobulin G4-kappa, anti-(human glucagon receptor (GL-R)); human monoclonal antibody: gamma4 heavy chain (1-455) [human VH (IGHV3-7*01-(IGHD)-IGHJ6*01) (93%) [8.8.21) (1-128) -IGHG4*01 H[S10>P (236)) (129-455) (142-214')-disulfide with kappa light chain (1'-214') (human V-KAPPA (IGKV1-17*01-IGKJ3*01) (96%) (6.3.9) (1'-107') -IGKC*01 (108'-214')) dimer (234-234'':237-237'')-bisdisulfide
  • REGN1193
  • UNII-4JQ68PW6XF

Systematic Name

  • Immunoglobulin G4, anti-(human glucagon receptor) (human monoclonal REGN1193 heavy chain), disulfide with human monoclonal REGN1193 kappa-chain, dimer

Registry Numbers

CAS Registry Number

  • 1452387-69-7

FDA UNII

  • 4JQ68PW6XF

System Generated Number

  • 1452387697